The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail


Novartis Europharm LimitedEU/1/20/1443/001-0037

Main Information

Trade NameZolgensma
Active SubstancesOnasemnogene Abeparvovec
Dosage FormSolution for infusion
Licence HolderNovartis Europharm Limited
Licence NumberEU/1/20/1443/001-0037

Group Information

ATC CodeM09AX Other drugs for disorders of the musculo-skeletal system
M09AX09 Onasemnogene Abeparvovec


License statusAuthorised
Licence Issued18/05/2020
Legal status*** AWAITING VALUE ***
Supply Status
Advertising Status*** AWAITING VALUE ***
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website

Educational Materials - HCP

Educational Materials - Patient

« Back